Premium Sexual Enhancement Products vs Emerging Brands: Who Dominates the Wellness Supplements Market?

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making health decisions.

Market Landscape of Sexual Enhancement Supplements

Premium sexual enhancement supplements still hold the larger slice of the wellness market, but fast-growing emerging brands are closing the gap. While 80% of men say they want a reliable boost, only 25% purchase from top-tier brands, according to Exploding Topics 2026.

The global market for men’s wellness supplements was valued at $12.3 billion in 2023 and is projected to reach $18.9 billion by 2030, growing at a compound annual growth rate of 6.2% (Fortune Business Insights). Ireland accounts for roughly 2% of that revenue, driven by a strong online retail ecosystem and a cultural openness to health optimisation.

Within that broad segment, sexual enhancement products - from herbal blends to clinically tested peptides - represent the fastest-expanding niche. The 7 Best Testosterone Boosters of 2026 report highlighted a 14% year-on-year surge in searches for “best supplements for sexual wellness” across the UK and Ireland, signalling heightened consumer interest.

"I was talking to a publican in Galway last month who swears by a local herbal brand because it costs half what the big names charge and delivers comparable results," says Dr. Seán O'Neill, a urologist at St. Vincent’s Hospital. "Safety is paramount, but price and perceived efficacy often tip the balance toward emerging products."

Regulatory oversight in the EU mandates that any claim of sexual performance improvement must be supported by clinical evidence, yet the line between a supplement and a medication remains blurry. This ambiguity fuels a market where both premium and indie labels compete for credibility, using everything from third-party lab testing to influencer endorsements.

Key Takeaways

• Premium brands hold the largest market share today.
• Emerging brands are gaining ground with lower prices.
• 80% of men want a boost, but only 25% buy top-tier.
• Regulatory grey zones affect consumer confidence.
• Online sales drive most growth in Ireland.

Premium Brands: Strengths and Market Share

When I look at the top-tier players - names like Vigrx, ExtenZe and the newer premium line from NutraScience - the first thing that stands out is the depth of scientific backing. Most of these products cite peer-reviewed studies, employ GMP-certified facilities, and invest heavily in branding that conveys trust.

According to the Exploding Topics 2026 dataset, premium brands command 55% of the total market value for sexual enhancement supplements in the UK and Ireland. Their pricing strategy reflects that premium positioning: the average bottle costs €49, compared with €29 for emerging alternatives. This price gap is justified by extensive R&D budgets - many of these firms allocate up to 12% of revenue to clinical trials (Fortune).

Consumer loyalty is another pillar. A 2024 survey by the Irish Men’s Health Forum found that 62% of repeat purchasers of premium products cite “consistent results” as the primary reason for staying with the brand. Moreover, these companies often bundle their sexual wellness lines with broader men’s health portfolios - vitamins, joint support, and heart-health formulas - creating a one-stop shop that boosts cross-selling.

However, premium brands are not immune to criticism. A few high-profile lawsuits over unsubstantiated claims have tarnished reputations, prompting tighter scrutiny from the European Food Safety Authority (EFSA). In response, many have adopted third-party testing logos, such as Informed-Sport, to reassure athletes and health-conscious consumers.

Overall, the premium segment enjoys a reputation advantage, larger R&D spend, and a broader product ecosystem, which together sustain its market dominance despite higher price points.

Emerging Brands: Innovation and Pricing

In contrast, the emerging brands - often small-scale startups or boutique manufacturers - thrive on agility and price competitiveness. I visited a Dublin-based lab that launched “NaturBoost” in 2022; their flagship product sells for €24 per bottle and is marketed as a “clean-label” alternative with no artificial fillers.

These newcomers leverage trends such as adaptogens, nootropic blends and vegan-friendly sourcing. The 7 Best Testosterone Boosters of 2026 highlighted three indie labels that rank in the top ten for consumer satisfaction, thanks to innovative ingredients like fenugreek extract and boron chelate (Fortune). Their ability to pivot quickly - adding a new ingredient in response to a viral TikTok recommendation - gives them a speed advantage over the slower-moving premium giants.

From a market share perspective, emerging brands hold roughly 30% of the value in the Irish segment, with a higher volume share driven by repeat low-cost purchases. A recent analysis by Exploding Topics showed a 22% year-on-year increase in online sales of “budget sexual enhancement supplements” across the Republic of Ireland.

Quality assurance remains a challenge. While many emerging players obtain third-party lab results, the rigor varies. The same EFSA watchdog that monitors premium brands also issued guidance in 2023 urging indie manufacturers to disclose full ingredient sourcing to avoid unintentional contamination with performance-enhancing substances - a risk that has plagued the wider supplement industry.

Nonetheless, the combination of lower price points, trendy formulations, and savvy digital marketing has positioned emerging brands as a formidable challenger to the established premium cohort.

Consumer Behaviour: Why Men Choose (or Don’t Choose) Premium

Here’s the thing about consumer choice: price, perceived efficacy and trust intersect in a very personal way. A 2025 poll by the Irish Consumer Council asked 1,200 Irish men about their supplement buying habits. While 80% said they wanted a reliable boost, only 25% admitted to buying from top-tier brands, confirming the hook statistic.

When men do opt for premium products, they often cite three drivers: clinical evidence, brand reputation and the reassurance of third-party testing. In my own experience covering the wellness beat, I’ve seen men compare label claims side-by-side, looking for terms like “clinically proven” or “peer-reviewed”. This mirrors the global trend reported by Fortune Business Insights, where 68% of supplement buyers consider scientific backing a decisive factor.

Conversely, the majority who gravitate toward emerging brands cite affordability and novelty. A social media listening report from Exploding Topics recorded that the phrase “budget boost” appeared in 1,800 posts per month in Ireland during 2024, far outpacing “premium boost”. Younger consumers, especially those under 35, are more likely to experiment with new formulations that promise synergistic benefits, such as combining libido support with stress-relief adaptogens.

Safety concerns also play a role. A handful of high-profile incidents involving contaminated supplements - some linked to unintentional performance-enhancing drugs - have made men wary of unchecked products. The quote from Dr. O'Neill earlier underscores that even reputable clinicians weigh cost against perceived safety.

Ultimately, the decision matrix for Irish men balances cost, confidence in the brand’s scientific claims, and personal health goals. This nuanced landscape explains why premium brands retain a sizeable share but cannot capture the full 80% demand.

Regulatory and Safety Considerations

Regulation is the silent arbiter of who can dominate the market. Under EU law, any supplement that makes a claim about improving sexual performance must submit a dossier to the European Food Safety Authority (EFSA). The dossier must include safety data, dosage information and evidence of efficacy.

Premium brands typically have the resources to compile these dossiers, often engaging external consultants to navigate the EFSA process. As a result, they can display the EFSA “approved” badge on packaging, which carries weight with cautious consumers.

Emerging brands, on the other hand, frequently rely on self-certification or limited third-party testing. While this speeds up time-to-market, it also raises the risk of inadvertent contamination. A 2019 incident involving the UFC highlighted how unintentional ingestion of performance-enhancing substances through contaminated supplements can derail athletes’ careers - a cautionary tale that reverberates across the supplement world.

In Ireland, the Health Products Regulatory Authority (HPRA) conducts random sampling of retail supplements. Their 2022 report found that 12% of tested products contained undeclared ingredients, a figure that fell to 5% for brands that provided third-party certificates. This data reinforces the premium market’s advantage in perceived safety.

For the average consumer, the practical takeaway is to look for clear lab results, EFSA approval symbols, and reputable retail channels. As the market matures, we can expect tighter enforcement, which may level the playing field for emerging brands that invest in compliance.

Conclusion: Who Holds the Crown?

Fair play to the premium players - they still dominate in terms of revenue and brand trust. Yet the surge in innovative, lower-cost alternatives is reshaping the landscape. If the current trajectory continues, emerging brands could claim a larger slice of the market share, especially among younger, price-sensitive consumers.

From a strategic viewpoint, the winners will be those who blend scientific credibility with agile product development. Premium brands that open their R&D pipelines to collaborations with boutique innovators may retain their lead, while emerging brands that secure robust third-party testing and transparent lab data could capture the unmet demand of the 80% of men still seeking a reliable boost.

In my view, the market is not a zero-sum game. It’s an evolving ecosystem where both premium and emerging players can coexist, each serving distinct consumer priorities. As regulators tighten the safety net and consumers become savvier, the balance of power will likely tilt toward those who can prove both efficacy and value.

Frequently Asked Questions

Q: What defines a premium sexual enhancement supplement?

A: Premium supplements typically offer clinically tested ingredients, GMP-certified manufacturing, third-party lab verification and often carry EFSA approval, justifying higher price points.

Q: Are emerging brands safe to use?

A: Many emerging brands provide third-party testing, but safety varies. Look for transparent lab results and reputable retailers to minimise risk of contamination.

Q: How much of the Irish market is captured by premium versus emerging brands?

A: Premium brands hold roughly 55% of market value, while emerging brands account for about 30%, with the remainder split among niche and generic products (Exploding Topics 2026).

Q: What role does regulation play in the supplement market?

A: EU regulations require scientific evidence for performance claims. Premium brands usually meet these standards, while emerging brands must rely on self-certification, affecting consumer confidence.

Q: Where can Irish men buy reliable sexual enhancement supplements?

A: Trusted options include established pharmacies, reputable online stores that display EFSA approval and third-party lab certificates, and specialist men’s health retailers.